All Stories

  1. An integrative network pharmacology, molecular docking, and molecular dynamics simulation approach to gain insights into the multi-target mechanisms of Anogeissus latifolia against urolithiasis
  2. Epilepsy: Real-time Monitoring with Biomarker and Biosensor Technology
  3. MicroRNAs in AD Management: Significant Approaches as Diagnostic Biomarkers
  4. Functional Implications of Marine Biosurfactants and Their Therapeutic Potential Against Alzheimer's Disease
  5. Good Clinical Practices for Clinical Trials of Herbal Medicine
  6. Polysaccharides in Cancer Prevention
  7. Polysaccharides in Targeted Therapy
  8. Design, Synthesis, and Mechanistic Studies of 5‐Substituted 2‐Oxindoles as Anticancer Agents
  9. Nanotechnology in dermatological surgery and aesthetic procedures
  10. Antimicrobial stewardship: Strategies, challenges, and case studies
  11. Ethical considerations in using wearable devices for health monitoring
  12. Gepirone: a selective partial agonist of the 5-HT1A receptor in the treatment of depression
  13. Medicinal and Nutritional Importance of Enhydra fluctuans in Human Health
  14. Recent updates on an alternative approach to tackle antimicrobial resistance: Secondary metabolites from natural sources
  15. [BMIM]OAc promoted one-pot synthesis of pyrazolo[4′,3′:5,6]pyrido[2,3- d ]pyrimidin-5-ones and their antimicrobial activity
  16. Ethical considerations and privacy in artificial intelligence-driven metaverse healthcare
  17. Nanoclays in ancient medical practice
  18. Potential applications of microbiome research in other areas of gastroenterology
  19. Stem cells and pyroptosis in cardiac injury
  20. Herb-Drug Interactions in Modern Healthcare
  21. Recent Developments in Cyclin-Dependent Kinase (CDK) PROTAC in Cancer Therapy
  22. Network pharmacology and molecular docking reveal multi-target mechanisms of Butea monosperma stem bark extract in ulcerative colitis
  23. Ethanol-mediated one-pot synthesis of 3-phenyl-3,4,5,12-tetrahydrobenzo[4,5]imidazo[2,1-b]quinazolin-1(2H)-ones as PDGFRA inhibitors
  24. C ‐5‐Arylidene‐Thiazolidine‐2,4‐Dione Analogs Against Aldose Reductase: Design, Synthesis, Biological Evaluation, and Computational Insights
  25. Bioengineered Decellularized Extracellular Matrices in Diabetic Ulcer Therapy: Therapeutic and Clinical Outlook
  26. Tyrosine Kinase as the Therapeutic Target for Neurodegenerative Diseases
  27. A study of Leonurine in chemically induced IgA nephropathy on Sprague Dawley rats
  28. Oxymatrine ameliorates epithelial mesenchymal transition in IgA nephropathy induced rats
  29. QSAR, Antimicrobial, and Antiproliferative Study of (R/S)-2-Thioxo-3,4-dihydropyrimidine-5-carboxanilides
  30. Innovative approaches to blood-brain barrier modelling: The chip revolution
  31. Nasal, transdermal delivery of probiotics
  32. Inhibiting brushite crystal growth: molecular docking exploration of Enhydra fluctuans phytoconstituents and their interaction with human serum albumin
  33. Bioinformatics for Determining the Active Site of a Target Proteins
  34. Immunoinformatics in Drug Designing
  35. Investigating the role of indole and quinazolinone-based hybrid analogues with ketoamide fragment and alkyl extension for potential PL inhibition
  36. Approaches Based on Network Pharmacology and Molecular Docking to Predict the Molecular Mechanism of Plumbago zeylanica's Anti-Inflammatory Action
  37. Indole clubbed 2,4‐thiazolidinedione linked 1,2,3‐triazole as a potent antimalarial and antibacterial agent against drug‐resistant strain and molecular modeling studies
  38. Gallstone: a factor for acute pancreatitis
  39. Role of liver in gallstone formation
  40. Role of the gallbladder in our metabolism and immune system
  41. Development of microRNA as prognostic markers in head and neck cancer
  42. Vaccine development strategies and impact
  43. FBDD & De Novo Drug Design
  44. Network pharmacology analysis of Plumbago zeylanica to identify the therapeutic targets and molecular mechanisms involved in ameliorating hemorrhoids
  45. In silico Molecular Docking and Scrutinizing Druglike Properties of Selected Phytoconstituents Against TAK1, Xanthin Oxidase, and IL-1 β Targets in Gouty Arthritis
  46. Enhydra fluctuans Lour. aqueous extract inhibited the growth of calcium phosphate crystals: An in vitro study
  47. Targeted Degradation of Structured RNAs via Ribonuclease-Targeting Chimeras (RiboTacs)
  48. Network pharmacology and molecular modelling study of Enhydra fluctuans for the prediction of the molecular mechanisms involved in the amelioration of nephrolithiasis
  49. Antiviral Drugs - in Past and Current Pandemics
  50. The Abundant Phytocannabinoids in Rheumatoid Arthritis: Therapeutic Targets and Molecular Processes Identified Using Integrated Bioinformatics and Network Pharmacology
  51. Inhibitory activity of Enhydra fluctuans Lour. on calcium oxalate crystallisation through in silico and in vitro studies
  52. Design, synthesis, biological evaluation and molecular modelling studies of oxoacetamide warhead containing indole-quinazolinone based novel hybrid analogues as potential pancreatic lipase inhibitors
  53. Insights into the Recent Synthetic Advances of Organoselenium Compounds